Developer docs
API playgroundTry for free, no card

Search company profiles

Lachman Consultant Services

Full company profile

uuid000bp58

Namestring
Lachman Consultant Services
Legal namestring
Lachman Consultant Services, Inc.
Company typeenum
Private
Founded yearint
1978
Descriptiontext

Lachman Consultant Services, Inc. is a privately held, independent FDA regulatory compliance and consulting firm founded in 1978 by Leon Lachman, Ph.D., and currently led by President & CEO Frances Zipp with Roy Sturgeon, Ph.D. as Chairman. Headquartered in Westbury, New York, with additional offices in Bethesda, Maryland, Dublin, Ireland, and Lucerne, Switzerland, the firm operates through three integrated practice groups: Compliance, Regulatory Affairs, and Science & Technology. Its bench consists of former senior-level FDA managers, FDA reviewers, and industry experts who deliver advisory, audit, and remediation services to pharmaceutical, biotechnology, biologics, medical device, advanced therapy (cell and gene therapy), and related life sciences companies.

The firm's core offering is high-skill professional services rather than software or technology products. Service lines span FDA document preparation and review (NDAs, INDs, ANDAs, 510(k)s, PMAs, DMFs, BLAs), compliance problem resolution, mock FDA inspections, data integrity programs, due diligence audits, facilities design and validation, systems evaluation, training programs, and remote consulting engagements. Underlying the offering are proprietary consulting methodologies and institutional knowledge of FDA processes accumulated over 47+ years, organized around vertical market expertise in pharmaceuticals, biologics, advanced therapies, medical devices, and related industries (API, diagnostics, dietary supplements, digital health, veterinary).

The business model is professional services consulting billed on a project/engagement basis at quote-based pricing, with revenue derived entirely from professional service fees. The go-to-market is relationship-driven direct sales leveraging industry reputation, thought leadership (blog, webinars, whitepapers, Lachman Learning series), active presence at major industry conferences (PDA, TIDES, CPhI, MedTech), and referrals from law firms and investment groups. The firm serves clients ranging from one-person startups to Fortune 500 multinational pharmaceutical companies, with primary end-markets in pharma, biologics/biotech, medical devices, and advanced therapies, and secondary segments in law firms, investment groups, and dietary supplement manufacturers.

Short descriptiontext

Lachman Consultant Services is a privately held FDA regulatory compliance and consulting firm founded in 1978, serving pharmaceutical, biotech, biologics, medical device, and advanced therapy companies with project-based advisory services delivered by former FDA officials across offices in the US, Ireland, and Switzerland.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWestbury, United States
HQ citystring
Westbury
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
FDA regulatory consulting, compliance services, regulatory affairs, pharmaceutical consulting, medical device consulting
Industry1 code
PRIMARYAFALADAC
Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA)
Agriculture & Food Production/Food Safety, Testing & Certification/Regulatory Compliance Testing & Consulting (FDA/USDA/EFSA, HACCP)
NAICS code3 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Other Scientific and Technical Consulting Services541690
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Regulatory Compliance Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory Compliance Consulting
TypeProfessional Services
Description

Professional consulting services billed on a project or engagement basis. Services include FDA regulatory affairs, compliance problem resolution, quality assurance, data integrity, mock FDA inspections, training, and technical assistance. Revenue is derived from professional service fees for advisory, audit, and consulting engagements with pharmaceutical, biotech, biologics, medical device, and related life sciences companies.

lachmanconsultants.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Lachman Consultants provides professional FDA regulatory compliance, regulatory affairs, and science & technology consulting services to pharmaceutical, biotechnology, biologics, medical device, and related life sciences companies. Services include regulatory filing preparation (NDAs, INDs, ANDAs, 510(k)s, PMAs, BLAs, DMFs), compliance problem resolution, mock FDA inspections, data integrity consulting, quality systems design, due diligence audits, and training, delivered by former senior-level FDA managers and industry experts.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Lachman Consultant Services is a regulatory compliance and consulting firm that operates as a unified service offering rather than a software platform. The company provides FDA compliance consulting and regulatory affairs services organized into distinct practice areas: FDA-Related Services (document preparation, compliance resolution, regulatory affairs assistance, training, audits), Compliance Services, Regulatory Affairs, Data Integrity Services, Mock FDA Inspections, Analytical Services, Biomonitoring Support, Strategic Planning, Due Diligence Audits, Quality Assurance and Controls, Scientific and Technical Assistance, Systems Evaluation, Facilities Design or Validation, System Process Validation or Qualification, Training Programs, and Remote Services. The firm serves multiple market verticals including Pharmaceuticals, Biologics, Advanced Therapies (cell and gene therapies), Medical Devices, and Related Industries (API, diagnostics, dietary supplements, digital health, veterinary products). Services are delivered by former FDA officials and industry experts, emphasizing hands-on consulting rather than software products.

Product and service18 records
1FDA-Related Services
Categorycore service
Description

Comprehensive FDA regulatory consulting including document preparation/reviews (NDAs, INDs, ANDAs, 510(k)s, PMAs, DMFs), compliance problem resolution, regulatory affairs strategic assistance, training, audits, pharmacovigilance/drug safety surveillance, and special services.

2Compliance Services
Categorycore service
Description

Full range of mission-critical compliance services including designing and implementing effective business processes, assuring sustainable compliance through integration of scientific, technical, and regulatory principles.

3Regulatory Affairs Consulting
Categorycore service
Description

Regulatory affairs consulting group comprised of former senior-level FDA managers and FDA reviewers providing assistance with regulatory filings, ANDAs, NDAs, DMFs, and other FDA regulatory forms.

4Data Integrity Services
Categorycore service
Description

GxP Data Integrity consulting critical to patient safety, regulatory compliance, and business success, covering managing vulnerabilities and risk across company operations for all GxP data.

5Mock FDA Inspections
Categorycore service
Description

Comprehensive mock FDA inspection services including facility inspections, documentation reviews, team training, and report generation to prepare clients for actual FDA inspections, delivered remotely and on-site.

6Analytical Services
Categorycore service
Description

Analytics services providing functionality and flexible, scalable usability that meets diverse user needs according to targeted business goals.

7Biomonitoring Support
Categorycore service
Description

Biomonitoring services addressing challenges of auditing and quantifying identity, purity, quality, safety, efficacy, and other requirements for authorization.

8Strategic Planning
Categorycore service
Description

Strategic planning services featuring global product development strategy, clinical/non-clinical/CMC/regulatory gap analysis, product and indication prioritization, and regulatory pathway optimization.

9Due Diligence Audits
Categorycore service
Description

Due diligence audit services for strategic mergers and acquisitions including assessment of compliance, identification of deficiencies, evaluation of supply chain and product pipeline capabilities.

10Quality Assurance and Controls
Categorycore service
Description

Quality assurance and control services including evaluating written procedures, developing laboratory systems and specifications, corporate oversight programs, and organizational structure assessments.

11System Process Validation or Qualification
Categorycore service
Description

System and process validation or qualification services including programmatic assistance, computer systems validation, 21 CFR Part 11 compliance, and validation/qualification policies and protocols.

12Training Programs
Categorycore service
Description

Regulatory compliance and affairs training programs for all organizational levels including GMP programs, regulatory programs, generic drugs program, and clinical/bioanalytical programs.

13Remote Services
Categorycore service
Description

Remote consulting services enabling expert support for quality systems implementation, policy and SOP writing, application review, audits, data integrity reviews, training, and FDA meeting preparation.

14Pharmaceuticals Consulting
Categorymarket vertical
Description

Pharmaceutical regulatory compliance consulting serving pharmaceutical companies, generic drug companies, OTC product companies, and contract manufacturers with quality systems design and regulatory submission support.

15Biologics Consulting
Categorymarket vertical
Description

Regulatory compliance and consulting services for biologics including monoclonal antibodies, cell and gene therapies, vaccines, and biosimilars with support across development and commercialization.

16Advanced Therapies Consulting
Categorymarket vertical
Description

Strategic compliance and regulatory support for cell and gene therapies, tissue-engineered products, and other ATMPs with expertise in FDA CBER/CDER and EMA ATMP frameworks.

17Medical Device Consulting
Categorymarket vertical
Description

Comprehensive regulatory and compliance support for medical device manufacturers including QMSR, EU MDR, and ISO 13485 requirements, 510(k), PMA, De Novo submissions, and quality systems auditing.

18Related Industries Consulting
Categorymarket vertical
Description

Regulatory consulting for related industries including API companies, diagnostics and IVD companies, dietary supplement manufacturers, compounding pharmacies, digital health and SaMD firms, and veterinary product manufacturers.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Advarra provides regulatory compliance, IRB, and technology-enabled consulting services to life sciences and clinical research sponsors. Its regulatory and quality consulting practice overlaps with Lachman's compliance and GCP-adjacent services.

TypeDirect peer
Description

ProPharma Group is a regulatory compliance, quality, and pharmacovigilance consulting firm serving pharma, biotech, and medical device companies. It is one of the closest direct competitors to Lachman, offering overlapping FDA consulting, mock inspections, and quality systems services.

TypeDirect peer
Description

PharmaLex provides regulatory affairs, quality, and pharmacovigilance consulting across the product lifecycle for pharma and biotech. Its service mix in regulatory strategy and compliance mirrors Lachman's core offerings, and its multi-jurisdiction footprint makes it a directly comparable peer.

TypeDirect peer
Description

NDA Group is a regulatory affairs and drug development consulting firm supporting pharma and biotech across FDA/EMA submissions. Its focus on regulatory strategy, CMC, and due diligence closely parallels Lachman's Regulatory Affairs and Science & Technology practice groups.

TypeDirect peer
Description

Voisin Consulting provides regulatory, clinical, and quality consulting for medical devices, IVDs, and combination products. It competes with Lachman specifically in the Medical Device consulting market, particularly for EU MDR and FDA pathway work.

TypeDirect peer
Description

Regulatory Pharma Net is a specialized regulatory affairs consultancy serving pharma and biotech with submission strategy and compliance services. It is a similarly sized, niche-focused peer competing directly with Lachman for FDA regulatory consulting engagements.

TypeBroad incumbent
Description

Parexel is a global CRO with a sizable regulatory and consulting practice serving pharma and biotech. It competes with Lachman for regulatory affairs and submission work but as part of a much broader clinical and commercialization portfolio.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with extensive regulatory affairs, quality compliance, and technology-enabled services. It competes broadly with Lachman across pharma/biotech regulatory work but as a one-stop-shop offering clinical, real-world, and commercial services.

TypeBroad incumbent
Description

ICON is a global CRO with a regulatory and consulting division serving pharma, biotech, and medical device sponsors. It overlaps with Lachman in regulatory strategy and quality but competes predominantly through large enterprise clinical engagements.

TypeBroad incumbent
Description

Charles River provides research, manufacturing, and consulting services to pharma and biotech, including regulatory and quality support. While its core is discovery and manufacturing, its consulting arm competes with Lachman in regulatory and CMC services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lachman Consultant Services

Regulatory Compliance Consultinglachmanconsultants.com

Lachman Consultant Services is a privately held FDA regulatory compliance and consulting firm founded in 1978, serving pharmaceutical, biotech, biologics, medical device, and advanced therapy companies with project-based advisory services delivered by former FDA officials across offices in the US, Ireland, and Switzerland.

What Lachman Consultant Services does

Lachman Consultant Services, Inc. is a privately held, independent FDA regulatory compliance and consulting firm founded in 1978 by Leon Lachman, Ph.D., and currently led by President & CEO Frances Zipp with Roy Sturgeon, Ph.D. as Chairman. Headquartered in Westbury, New York, with additional offices in Bethesda, Maryland, Dublin, Ireland, and Lucerne, Switzerland, the firm operates through three integrated practice groups: Compliance, Regulatory Affairs, and Science & Technology. Its bench consists of former senior-level FDA managers, FDA reviewers, and industry experts who deliver advisory, audit, and remediation services to pharmaceutical, biotechnology, biologics, medical device, advanced therapy (cell and gene therapy), and related life sciences companies.

The firm's core offering is high-skill professional services rather than software or technology products. Service lines span FDA document preparation and review (NDAs, INDs, ANDAs, 510(k)s, PMAs, DMFs, BLAs), compliance problem resolution, mock FDA inspections, data integrity programs, due diligence audits, facilities design and validation, systems evaluation, training programs, and remote consulting engagements. Underlying the offering are proprietary consulting methodologies and institutional knowledge of FDA processes accumulated over 47+ years, organized around vertical market expertise in pharmaceuticals, biologics, advanced therapies, medical devices, and related industries (API, diagnostics, dietary supplements, digital health, veterinary).

The business model is professional services consulting billed on a project/engagement basis at quote-based pricing, with revenue derived entirely from professional service fees. The go-to-market is relationship-driven direct sales leveraging industry reputation, thought leadership (blog, webinars, whitepapers, Lachman Learning series), active presence at major industry conferences (PDA, TIDES, CPhI, MedTech), and referrals from law firms and investment groups. The firm serves clients ranging from one-person startups to Fortune 500 multinational pharmaceutical companies, with primary end-markets in pharma, biologics/biotech, medical devices, and advanced therapies, and secondary segments in law firms, investment groups, and dietary supplement manufacturers.

Lachman Consultant Services firmographics

Firmographics
Name
Lachman Consultant Services
Legal name
Lachman Consultant Services, Inc.
Website
https://lachmanconsultants.com
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
101–250 employees
Short description
Lachman Consultant Services is a privately held FDA regulatory compliance and consulting firm founded in 1978, serving pharmaceutical, biotech, biologics, medical device, and advanced therapy companies with project-based advisory services delivered by former FDA officials across offices in the US, Ireland, and Switzerland.
Ownership category
akta.pro rank

Lachman Consultant Services industry classification

Industry
Product category
Regulatory Compliance Consulting
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYAFALADAC
Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA)
Agriculture & Food Production/Food Safety, Testing & Certification/Regulatory Compliance Testing & Consulting (FDA/USDA/EFSA, HACCP)

Keywords

  • FDA regulatory consulting
  • Compliance services
  • Regulatory affairs
  • Pharmaceutical consulting
  • Medical device consulting

Where Lachman Consultant Services is headquartered

Location

Headquarters

HQ city
Westbury
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Lachman Consultant Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Regulatory Compliance Consulting: Professional consulting services billed on a project or engagement basis. Services include FDA regulatory affairs, compliance problem resolution, quality assurance, data integrity, mock FDA inspections, training, and technical assistance. Revenue is derived from professional service fees for advisory, audit, and consulting engagements with pharmaceutical, biotech, biologics, medical device, and related life sciences companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Lachman Consultant Services product offering

Product offering

Core offering

Lachman Consultants provides professional FDA regulatory compliance, regulatory affairs, and science & technology consulting services to pharmaceutical, biotechnology, biologics, medical device, and related life sciences companies. Services include regulatory filing preparation (NDAs, INDs, ANDAs, 510(k)s, PMAs, BLAs, DMFs), compliance problem resolution, mock FDA inspections, data integrity consulting, quality systems design, due diligence audits, and training, delivered by former senior-level FDA managers and industry experts.

Product overview

Lachman Consultant Services is a regulatory compliance and consulting firm that operates as a unified service offering rather than a software platform. The company provides FDA compliance consulting and regulatory affairs services organized into distinct practice areas: FDA-Related Services (document preparation, compliance resolution, regulatory affairs assistance, training, audits), Compliance Services, Regulatory Affairs, Data Integrity Services, Mock FDA Inspections, Analytical Services, Biomonitoring Support, Strategic Planning, Due Diligence Audits, Quality Assurance and Controls, Scientific and Technical Assistance, Systems Evaluation, Facilities Design or Validation, System Process Validation or Qualification, Training Programs, and Remote Services. The firm serves multiple market verticals including Pharmaceuticals, Biologics, Advanced Therapies (cell and gene therapies), Medical Devices, and Related Industries (API, diagnostics, dietary supplements, digital health, veterinary products). Services are delivered by former FDA officials and industry experts, emphasizing hands-on consulting rather than software products.

Differentiator

Problem solved

Functional benefit

Products and services

  • FDA-Related Services Comprehensive FDA regulatory consulting including document preparation/reviews (NDAs, INDs, ANDAs, 510(k)s, PMAs, DMFs), compliance problem resolution, regulatory affairs strategic assistance, training, audits, pharmacovigilance/drug safety surveillance, and special services.
  • Compliance Services Full range of mission-critical compliance services including designing and implementing effective business processes, assuring sustainable compliance through integration of scientific, technical, and regulatory principles.
  • Regulatory Affairs Consulting Regulatory affairs consulting group comprised of former senior-level FDA managers and FDA reviewers providing assistance with regulatory filings, ANDAs, NDAs, DMFs, and other FDA regulatory forms.
  • Data Integrity Services GxP Data Integrity consulting critical to patient safety, regulatory compliance, and business success, covering managing vulnerabilities and risk across company operations for all GxP data.
  • Mock FDA Inspections Comprehensive mock FDA inspection services including facility inspections, documentation reviews, team training, and report generation to prepare clients for actual FDA inspections, delivered remotely and on-site.
  • Analytical Services Analytics services providing functionality and flexible, scalable usability that meets diverse user needs according to targeted business goals.
  • Biomonitoring Support Biomonitoring services addressing challenges of auditing and quantifying identity, purity, quality, safety, efficacy, and other requirements for authorization.
  • Strategic Planning Strategic planning services featuring global product development strategy, clinical/non-clinical/CMC/regulatory gap analysis, product and indication prioritization, and regulatory pathway optimization.
  • Due Diligence Audits Due diligence audit services for strategic mergers and acquisitions including assessment of compliance, identification of deficiencies, evaluation of supply chain and product pipeline capabilities.
  • Quality Assurance and Controls Quality assurance and control services including evaluating written procedures, developing laboratory systems and specifications, corporate oversight programs, and organizational structure assessments.
  • System Process Validation or Qualification System and process validation or qualification services including programmatic assistance, computer systems validation, 21 CFR Part 11 compliance, and validation/qualification policies and protocols.
  • Training Programs Regulatory compliance and affairs training programs for all organizational levels including GMP programs, regulatory programs, generic drugs program, and clinical/bioanalytical programs.
  • Remote Services Remote consulting services enabling expert support for quality systems implementation, policy and SOP writing, application review, audits, data integrity reviews, training, and FDA meeting preparation.
  • Pharmaceuticals Consulting Pharmaceutical regulatory compliance consulting serving pharmaceutical companies, generic drug companies, OTC product companies, and contract manufacturers with quality systems design and regulatory submission support.
  • Biologics Consulting Regulatory compliance and consulting services for biologics including monoclonal antibodies, cell and gene therapies, vaccines, and biosimilars with support across development and commercialization.
  • Advanced Therapies Consulting Strategic compliance and regulatory support for cell and gene therapies, tissue-engineered products, and other ATMPs with expertise in FDA CBER/CDER and EMA ATMP frameworks.
  • Medical Device Consulting Comprehensive regulatory and compliance support for medical device manufacturers including QMSR, EU MDR, and ISO 13485 requirements, 510(k), PMA, De Novo submissions, and quality systems auditing.
  • Related Industries Consulting Regulatory consulting for related industries including API companies, diagnostics and IVD companies, dietary supplement manufacturers, compounding pharmacies, digital health and SaMD firms, and veterinary product manufacturers.

Companies that use Lachman Consultant Services

Customer profile

Segments6 records

Ideal customer profiles5 records

Lachman Consultant Services technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Lachman Consultant Services partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves8 records

Expansion highlights4 records

Lachman Consultant Services competitors and assessment

Company assessment

Direct peers

  • Advarra: Advarra provides regulatory compliance, IRB, and technology-enabled consulting services to life sciences and clinical research sponsors. Its regulatory and quality consulting practice overlaps with Lachman's compliance and GCP-adjacent services.
  • ProPharma Group: ProPharma Group is a regulatory compliance, quality, and pharmacovigilance consulting firm serving pharma, biotech, and medical device companies. It is one of the closest direct competitors to Lachman, offering overlapping FDA consulting, mock inspections, and quality systems services.
  • PharmaLex: PharmaLex provides regulatory affairs, quality, and pharmacovigilance consulting across the product lifecycle for pharma and biotech. Its service mix in regulatory strategy and compliance mirrors Lachman's core offerings, and its multi-jurisdiction footprint makes it a directly comparable peer.
  • NDA Group: NDA Group is a regulatory affairs and drug development consulting firm supporting pharma and biotech across FDA/EMA submissions. Its focus on regulatory strategy, CMC, and due diligence closely parallels Lachman's Regulatory Affairs and Science & Technology practice groups.
  • Voisin Consulting Life Sciences: Voisin Consulting provides regulatory, clinical, and quality consulting for medical devices, IVDs, and combination products. It competes with Lachman specifically in the Medical Device consulting market, particularly for EU MDR and FDA pathway work.
  • Regulatory Pharma Net: Regulatory Pharma Net is a specialized regulatory affairs consultancy serving pharma and biotech with submission strategy and compliance services. It is a similarly sized, niche-focused peer competing directly with Lachman for FDA regulatory consulting engagements.

Broad incumbents

  • Parexel International: Parexel is a global CRO with a sizable regulatory and consulting practice serving pharma and biotech. It competes with Lachman for regulatory affairs and submission work but as part of a much broader clinical and commercialization portfolio.
  • IQVIA: IQVIA is the world's largest CRO with extensive regulatory affairs, quality compliance, and technology-enabled services. It competes broadly with Lachman across pharma/biotech regulatory work but as a one-stop-shop offering clinical, real-world, and commercial services.
  • ICON plc: ICON is a global CRO with a regulatory and consulting division serving pharma, biotech, and medical device sponsors. It overlaps with Lachman in regulatory strategy and quality but competes predominantly through large enterprise clinical engagements.
  • Charles River Laboratories: Charles River provides research, manufacturing, and consulting services to pharma and biotech, including regulatory and quality support. While its core is discovery and manufacturing, its consulting arm competes with Lachman in regulatory and CMC services.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Lachman Consultant Services social profiles

Digital presence

Lachman Consultant Services compliance and trust

Trust signal

Compliance1 record

Lachman Consultant Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lachman Consultant Services leadership team

Management profile

Number of profiles

Profiles10 records

Lachman Consultant Services subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Lachman Consultant Services funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lachman Consultant Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lachman Consultant Services

What does Lachman Consultant Services do?

Lachman Consultants provides professional FDA regulatory compliance, regulatory affairs, and science & technology consulting services to pharmaceutical, biotechnology, biologics, medical device, and related life sciences companies. Services include regulatory filing preparation (NDAs, INDs, ANDAs, 510(k)s, PMAs, BLAs, DMFs), compliance problem resolution, mock FDA inspections, data integrity consulting, quality systems design, due diligence audits, and training, delivered by former senior-level FDA managers and industry experts.

Is Lachman Consultant Services a public or private company?

Lachman Consultant Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Lachman Consultant Services founded?

Lachman Consultant Services was founded in 1978. It employs 101 to 250 people.

Where is Lachman Consultant Services based?

Lachman Consultant Services is headquartered in Westbury, United States, in the North America region.

How does Lachman Consultant Services make money?

One revenue line is on record: regulatory Compliance Consulting.

Who are Lachman Consultant Services's main competitors?

Direct peers on record are Advarra, ProPharma Group, PharmaLex, NDA Group, Voisin Consulting Life Sciences and Regulatory Pharma Net. Broad incumbents are Parexel International, IQVIA, ICON plc and Charles River Laboratories.

Does Lachman Consultant Services have an API?

No public API is recorded for Lachman Consultant Services.

What industry is Lachman Consultant Services in?

Lachman Consultant Services's product category is Regulatory Compliance Consulting. Its primary akta.pro industry code is AFALADAC, Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ContractpharmaRegulatory Affairs: A Common Warning Letter Citation ExploredThe FDA warning letter citation requires manufacturers to test each component for conformity with written specifications for purity, strength, and quality. For compendial articles, the applicable USP or NF monograph sets minimum testing requirements, and failure to meet them renders the component adulterated. The article notes this deficiency often occurs with compendial components, and Lachman Consultants offers guidance.ContractpharmaFDA Watch: Is Your Supply Chain at Risk?Lachman Consultants' Patrick Day argues that pharmaceutical supply chains must integrate FDA risk-management guidance and quality-risk-management (QRM) into multi-year strategies. He cites FDA and EMA documents and notes that compliance alone is insufficient, requiring incentives for pharmaceutical quality system excellence. He urges companies to adopt data-governance and AI for early detection of shortages.PrwebLachman Consultants, Inc. Names John McShane, M.B.A., as VP of Cell & Gene Therapy, Compliance and Business DevelopmentJohn McShane joined Lachman Consultants as VP of Cell & Gene Therapy, Compliance and Business Development, leading the division's regulatory and compliance standards. He previously served as Managing Partner at Validant Consulting and held director roles at Genentech/Roche. The appointment aims to support biopharmaceutical clients in cell and gene therapy development.PrwebNew Webinar Series From Lachman Consultants Provides Valuable Information To The Pharmaceutical IndustryLachman Consultants will launch a webinar series on FDA inspections, starting May 14 with "Preparing for and Handling an FDA Inspection". The series includes a second webinar on May 21 covering responses to inspectional observations. The webinars aim to provide guidance to life science organizations amid health and economic concerns.PrwebAccomplished Global Pharma Executive Mary Oates Joins Lachman Consultants, Inc. as VP of Compliance ServicesMary Oates joined Lachman Consultants as Vice President of Compliance Services, leading the firm's Compliance Practice Group. She previously held quality and regulatory leadership roles at Pfizer, including head of Global Quality Operations. Oates brings nearly 30 years of experience in pharmaceutical compliance.